Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic regulation of multielectron iodine chemistry in aqueous zinc-iodine batteries.

Chemical communications (Cambridge, England)·2026
Same author

Rag GTPases and mTORC1 regulate intestinal stem cell activity in response to nutrient availability.

The Journal of cell biology·2026
Same author

Automated Calls Added to SMS Reminders Reduce Missed Appointments among High-Risk Patients.

NEJM catalyst innovations in care delivery·2026
Same author

Engineering manganese-based immune amplifier for chemoimmunotherapy of peritoneal metastatic colorectal cancer.

Materials today. Bio·2026
Same author

Clinician contributions to disparities in severity of illness trajectories among mechanically ventilated patients.

medRxiv : the preprint server for health sciences·2026
Same author

Loss of NRF2 During Aging Contributes to Myocardial Functional Decline.

Antioxidants (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jul 7, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.3K

Semi-reference based cell type deconvolution with application to human metastatic cancers.

Yingying Lu1, Qin M Chen2,3, Lingling An1,4,5

  • 1Interdisciplinary Program in Statistics and Data Science, University of Arizona, Tucson, AZ, USA.

NAR Genomics and Bioinformatics
|December 25, 2023
PubMed
Summary

This study introduces SECRET, a novel method to accurately estimate cell type proportions from bulk RNA sequencing data using single-cell RNA sequencing profiles. SECRET enhances cancer research by revealing cell type contributions in bulk samples.

More Related Videos

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.1K
Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells
07:10

Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells

Published on: July 29, 2016

12.7K

Related Experiment Videos

Last Updated: Jul 7, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.3K
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.1K
Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells
07:10

Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells

Published on: July 29, 2016

12.7K

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • Bulk RNA sequencing (RNA-seq) provides average gene expression but misses crucial cell type-specific insights.
  • Understanding cellular heterogeneity is vital for phenotype and disease variation studies.
  • Single-cell RNA sequencing (scRNA-seq) offers detailed cellular analysis but is costly and analytically challenging for large sample sizes.

Purpose of the Study:

  • To develop a novel computational method for deconvoluting cell type proportions from bulk RNA-seq data.
  • To leverage scRNA-seq reference profiles for accurate cell type estimation in bulk samples.
  • To enhance the flexibility and applicability of deconvolution methods in cancer research.

Main Methods:

  • Introduction of SECRET, a deconvolution approach utilizing cell type-specific gene expression profiles from scRNA-seq.
  • SECRET adapts to reference datasets lacking specific cell types present in bulk samples.
  • Validation using synthetic data and application to real human metastatic cancer samples.

Main Results:

  • SECRET demonstrates superior accuracy in estimating cell type proportions compared to existing methods.
  • The method successfully identified previously unknown tissue-specific cell types in human metastatic cancers.
  • SECRET offers increased flexibility in reference selection for deconvolution analyses.

Conclusions:

  • SECRET provides a robust and flexible solution for cell type deconvolution from bulk RNA-seq data.
  • This approach significantly advances the analysis of cellular heterogeneity in cancer studies.
  • SECRET's versatility supports broad applications across diverse human cancer research.